Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 300 of 537 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/01/18
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 10/31/08
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 05/31/21
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 08/01/20
End: 04/01/22
Due: 04/01/23
Phase: N/A
Priority: Normal
Start: 11/30/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 11/28/20
End: 07/06/23
Due: 07/06/24
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 08/31/19
Due: 08/31/20
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 03/31/11
Due: 03/31/12
Phase: N/A
Priority: Normal
Start: 07/31/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/01/22
End: 05/30/29
Due: 05/30/30
Phase: N/A
Priority: Normal
Start: 10/12/18
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 01/31/19
Due: 01/31/20
Phase: N/A
Priority: Normal
Start: 03/31/15
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/05/17
End: 08/23/18
Due: 08/23/19
Phase: N/A
Priority: Normal
Start: 05/31/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/08
End: -
Due: -
Effect of HCCD Supplemented With Omega-3 Fatty-Acids on Inflammation in Healthy, Overweight Subjects
Phase: N/A
Priority: Normal
Start: 01/31/08
End: 12/31/09
Due: 12/31/10
Phase: N/A
Priority: Normal
Start: 12/31/10
End: 10/31/12
Due: 10/31/13
Phase: N/A
Priority: Normal
Start: 11/30/16
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 11/30/07
End: 11/30/08
Due: 11/30/09
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 11/30/13
Due: 11/30/14
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 05/31/09
End: 04/30/12
Due: 04/30/13